Related Experiment Video
Updated: Apr 5, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
2-Methoxyestradiol: A Hormonal Metabolite Modulates Stimulated T-Cells Function and proliferation
J G Y Luc1, R Paulin2, J Y Zhao1
1Division of Cardiac Surgery, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada; Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.
Background:
2-Methoxyestradiol (2ME2) is an endogenous metabolite of estrogen that is nonestrogenic and has been studied in cancer as an antimitotic agent that is beneficial by its selectivity for cancer cells without toxicity to nonmalignant cells. Because the effect of 2ME2 in a transplant rejection setting remains unknown, we hypothesized that 2ME2 can inhibit stimulated T-cell function.
Methods:
Human peripheral blood mononuclear cells (PBMCs) were cultured and pretreated with 2ME2 before stimulation. The cultured medium was collected for enzyme-linked immunosorbent assays, and whole-cell lysates were collected for Western immunoblotting. Proliferation and apoptosis assays were performed and analyzed by means of flow cytometry.
Results:
Tumor necrosis factor -α and interferon-γ cytokine production in 2ME2-treated stimulated PBMCs were modestly reduced relative to control samples. T-cell proliferation was blunted by treatment with 2ME2, and a decrease in apoptosis correlated with a decrease in caspase-9 activity. Additionally, 2ME2 was able to block stress-induced senescence caused by stimulation of T-cells.
Conclusions:
2ME2 is a hormone-based therapy that blunts stimulated T-cell proliferation and does not induce apoptosis or stress-induced senescence. Stimulated T-cells treated with 2ME2 are still able to produce normal levels of cytokines. Therefore, 2ME2 may lead to an oral immunomodulatory adjunct therapy with a low side effect profile for individuals undergoing transplantation.
Insights
2-Methoxyestradiol (2ME2), an estrogen metabolite, inhibits T-cell proliferation without inducing apoptosis or senescence. This suggests 2ME2 could be a safe oral immunomodulatory therapy for transplant patients.
Area of Science:
- Immunology
- Endocrinology
- Pharmacology
Background:
- 2-Methoxyestradiol (2ME2) is a nonestrogenic endogenous estrogen metabolite.
- It exhibits antimitotic properties, selectively targeting cancer cells without harming normal cells.
- Its effects on transplant rejection and T-cell function were previously unknown.
Purpose of the Study:
- To investigate the potential of 2ME2 in modulating T-cell responses in the context of transplant rejection.
- To test the hypothesis that 2ME2 can inhibit stimulated T-cell function.
Main Methods:
- Human peripheral blood mononuclear cells (PBMCs) were treated with 2ME2 prior to stimulation.
- Assays included enzyme-linked immunosorbent assays (ELISAs), Western immunoblotting, proliferation assays, and flow cytometry for apoptosis and senescence.
- Caspase-9 activity was also assessed.
Main Results:
- 2ME2 treatment modestly reduced TNF-α and IFN-γ cytokine production in stimulated PBMCs.
- T-cell proliferation was significantly blunted by 2ME2.
- A decrease in apoptosis correlated with reduced caspase-9 activity, and 2ME2 blocked stress-induced senescence.
Conclusions:
- 2ME2 effectively blunts stimulated T-cell proliferation without inducing apoptosis or senescence.
- T-cells treated with 2ME2 maintain normal cytokine production levels.
- 2ME2 shows promise as an oral immunomodulatory adjunct therapy for transplantation with a favorable side effect profile.
More Related Videos
08:13Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
Published on: December 27, 2016
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Mitogens and the Cell Cycle
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...